PhiliposeGetachewMulugetaMD
Nuclear Medicine • Philadelphia, PAAssociate Professor of Clinical Radioloy, University of Pennsylvania
Dr. Mulugeta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 410-737-5085
Summary
- Dr. Philipose Mulugeta is a nuclear medicine physician in Philadelphia, PA. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 6 years. He is experienced in prostate cancer, neuroendocrine tumors, radio-iodine therapy, tumor imaging, and therapeutic nuclear medicine.
Education & Training
University of Pennsylvania Health SystemFellowship, Nuclear Radiology, 2016 - 2017- University of Pennsylvania Health SystemResidency, Radiology-Diagnostic, 2012 - 2016
Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2011 - 2012
Vanderbilt University School of MedicineClass of 2011
Certifications & Licensure
PA State Medical License 2013 - 2026
NJ State Medical License 2023 - 2025
DC State Medical License 2017 - 2024
HI State Medical License 2022 - 2024
VA State Medical License 2017 - 2024
GA State Medical License 2021 - 2023
MD State Medical License 2017 - 2023- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic & Medical Nuclear Physics
- American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- Management of Dry Mouth Toxicity FollowingLu-PSMA-617 Radioligand Therapy.Abigail Pepin, Ana Kiess, J Nicholas Lukens, Philipose Mulugeta, Neil K Taunk
Practical Radiation Oncology. 2024-11-09 - 1 citationsMolecular Imaging and Therapy of Differentiated Thyroid Carcinoma in Adults.Philipose Getachew Mulugeta, Anthony W Chi, Thomas Michael Anderson
Cancer Journal. 2024-05-16 - 1 citationsManagement of Dry Eye Toxicity After Treatment WithLu-PSMA-617 Radioligand Therapy.Abigail Pepin, Vivian Lee, Sophia O'Brien, Philipose Mulugeta, Neil K Taunk
Practical Radiation Oncology. 2024-04-16
Professional Memberships
- Society of Nuclear Medicine and Molecular Imaging (SNMMI)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
